(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 8.34% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.15%.
Progyny's revenue in 2026 is $1,293,127,000.On average, 13 Wall Street analysts forecast PGNY's revenue for 2026 to be $110,605,306,440, with the lowest PGNY revenue forecast at $105,357,037,650, and the highest PGNY revenue forecast at $115,148,583,900. On average, 13 Wall Street analysts forecast PGNY's revenue for 2027 to be $120,161,855,580, with the lowest PGNY revenue forecast at $110,526,974,070, and the highest PGNY revenue forecast at $129,091,745,760.
In 2028, PGNY is forecast to generate $128,465,086,800 in revenue, with the lowest revenue forecast at $116,401,901,820 and the highest revenue forecast at $137,081,647,500.